Market Size of United States Blood Glucose Monitoring Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Market Size (2024) | USD 14.24 Billion |
Market Size (2029) | USD 26.23 Billion |
CAGR (2024 - 2029) | 13.00 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
US Blood Glucose Monitoring Market Analysis
The United States Blood Glucose Monitoring Market size is estimated at USD 14.24 billion in 2024, and is expected to reach USD 26.23 billion by 2029, growing at a CAGR of 13% during the forecast period (2024-2029).
Diabetic patients were at a higher risk of hospitalizations and complications during the COVID-19 pandemic due to hyper- or hypoglycemia, metabolic comorbidities, and a more severe SARS-CoV-2 infection.The maintenance of euglycemia was important to decrease both morbidity and mortality in the hospital setting. According to experts, inpatient use of diabetes technology in patients with proper institutional protocols was safe, improved inpatient glycemic outcomes, and played a vital role in managing hypoglycemia and hyperglycemia in hospitalized patients.
Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Blood glucose measurement helps find out how well blood glucose is being used and how well glucose is being controlled in the body.Over time, the readings provide the patient and their health professionals with the information required to determine the best management strategy for diabetes. When blood glucose levels are too high or too low, they can be managed successfully, which keeps health problems related to diabetes to a minimum.
According to the National Center for Health Statistics, approximately 32.8% of adults aged 18 and over in the United States will be obese in 2021. In obese individuals, the fat cells in the body release pro-inflammatory chemicals, which may make the body less sensitive to the insulin it produces by disrupting the function of insulin-responsive cells. Thus, these individuals need external insulin shots and are obligated to use a blood glucose monitoring device, such as a glucometer.
Technological advancements in blood glucose meters, including cellular-connected devices that automatically upload SMBG data to secure cloud-based databases, allow for improved sharing and monitoring of SMBG data. Real-time monitoring of SMBG data presents opportunities to provide timely support to patients who are responsive to abnormal SMBG recordings. Such diabetes remote monitoring programs can give people with T2D who don't have it well under control the extra help they need to improve critical outcomes, which will help the market in the years to come.
US Blood Glucose Monitoring Industry Segmentation
Blood glucose monitoring tests the concentration of glucose in the blood (glycemia). Particularly important in diabetes management, a blood glucose test is typically performed to determine the fluctuation in blood glucose level and to take or alter the medication accordingly, especially for insulin users. Achieving optimum glycemic results can be very difficult without frequent monitoring of blood glucose levels. The United States blood glucose monitoring market is segmented by type (self-monitoring blood glucose devices and continuous blood glucose monitoring devices) and components (glucometer devices, test strips, lancets, sensors, and durables). The report offers the value (in USD million) and volume (in unit million) for the above segments.
Self-monitoring blood glucose devices (Value and Volume, 2017 - 2028) | |
Glucometer Devices | |
Test Strips | |
Lancets |
Continuous blood glucose monitoring devices (Value and Volume, 2017 - 2028) | |
Sensors | |
Durables (Receivers and Transmitters) |
United States Blood Glucose Monitoring Market Size Summary
The United States Blood Glucose Monitoring Market is poised for significant growth over the forecast period, driven by the increasing prevalence of diabetes and obesity-related conditions. The market is characterized by technological advancements in blood glucose monitoring devices, such as continuous glucose monitoring (CGM) systems and cellular-connected meters, which enhance real-time data sharing and monitoring. These innovations are crucial for managing diabetes effectively, particularly in populations with limited access to traditional healthcare resources. The market landscape is moderately fragmented, with key players like Abbott, Dexcom, and Medtronic leading the charge in research and development to improve device accuracy and user experience. The focus on addressing social determinants of health and the integration of diabetes management platforms by startups further contribute to the market's dynamic nature.
The demand for blood glucose monitoring devices is expected to rise as more individuals seek effective management solutions for diabetes, particularly type 2 diabetes, which is more prevalent among underserved communities. The market's growth is supported by regulatory endorsements and global health initiatives aimed at improving diabetes care and access to essential medications. Continuous glucose monitoring systems, in particular, are gaining traction due to their ability to provide real-time glucose level insights without the need for frequent fingerstick tests. The market's expansion is also fueled by strategic mergers and acquisitions, such as Dexcom's acquisition of TypeZero Technologies, which enhance the development of integrated diabetes management systems. As awareness and adoption of advanced diabetes devices increase, the market is set to experience robust growth, addressing the critical need for effective diabetes management solutions in the United States.
United States Blood Glucose Monitoring Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Drivers
-
1.3 Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Self-monitoring blood glucose devices (Value and Volume, 2017 - 2028)
-
2.1.1 Glucometer Devices
-
2.1.2 Test Strips
-
2.1.3 Lancets
-
-
2.2 Continuous blood glucose monitoring devices (Value and Volume, 2017 - 2028)
-
2.2.1 Sensors
-
2.2.2 Durables (Receivers and Transmitters)
-
-
United States Blood Glucose Monitoring Market Size FAQs
How big is the United States Blood Glucose Monitoring Market?
The United States Blood Glucose Monitoring Market size is expected to reach USD 14.24 billion in 2024 and grow at a CAGR of 13% to reach USD 26.23 billion by 2029.
What is the current United States Blood Glucose Monitoring Market size?
In 2024, the United States Blood Glucose Monitoring Market size is expected to reach USD 14.24 billion.